Lindsay A. Rosenwald M.D.
President, CEO & Chairman at Fortress Biotech Inc.
Sits on 3 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 17 years
- Director since
- 2016
17 years of board service in total across 3 boards, counting each seat separately. Longest: Mustang Bio Inc., 10 years.
Mustang Bio Inc.
Director
Fortress Biotech Inc.
Director · PRESIDENT, CEO & CHAIRMAN
Journey Medical Corporation
Director
Chief executive roles
Fortress Biotech Inc.
· President, CEO & Chairman
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 25, 2026 | Journey Medical Corporation | Grant or award | +10,000 | — | — |
| Mar 18, 2026 | Fortress Biotech Inc. | Grant or award | +475,424 | — | — |
| Aug 5, 2025 | Journey Medical Corporation | Grant or award | +50,000 | — | — |
| Jun 25, 2025 | Journey Medical Corporation | Grant or award | +7,173 | — | — |
| Jan 1, 2025 | Fortress Biotech Inc. | Grant or award | +454,153 | — | — |
| Sep 23, 2024 | Fortress Biotech Inc. | Open-market purchase | +763,359 | $1.84 | $1,404,581 |
| Jul 11, 2024 | Fortress Biotech Inc. | Open-market purchase | +5,000 | $7.48 | $37,400 |
| Jul 9, 2024 | Fortress Biotech Inc. | Open-market purchase | +5,000 | $7.39 | $36,950 |
| Jul 8, 2024 | Journey Medical Corporation | Grant or award | +9,728 | — | — |
| Jul 8, 2024 | Fortress Biotech Inc. | Open-market purchase | +5,000 | $7.35 | $36,750 |
| Jun 28, 2024 | Fortress Biotech Inc. | Open-market purchase | +20,000 | $1.64 | $32,800 |
| May 16, 2024 | Fortress Biotech Inc. | Open-market purchase | +10,000 | $1.76 | $17,600 |
| Mar 25, 2024 | Journey Medical Corporation | Open-market purchase | +10,000 | $3.04 | $30,400 |
| Mar 22, 2024 | Journey Medical Corporation | Open-market purchase | +20,000 | $3.40 | $68,000 |
| Jan 5, 2024 | Fortress Biotech Inc. | Open-market purchase | +50,000 | $2.38 | $119,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.